Cargando...
A consensus statement regarding the utilization of BMP in spine surgery
Recombinant human bone morphogenetic protein - 2 (rh-BMP-2) was first approved by the United States Food and Drug Administration (FDA) in 2002 for use in anterior lumbar interbody fusions. Since that time, it has been estimated that “off label” use accounts for 85 % of applications. Original, indust...
Guardado en:
| Publicado en: | Curr Rev Musculoskelet Med |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Springer US
2014
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4596161/ https://ncbi.nlm.nih.gov/pubmed/24947400 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12178-014-9224-0 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|